Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261

Dieter Weinand

Dieter is Chairman of the Board of Inspirna

Dieter Weinand is the former CEO of Bayer Pharma AG, and is an experienced business leader with over 25 years of experience in the pharmaceutical industry. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York. During a career stretching back over 25 years, he has held various responsibilities in general management, commercial, operational and strategic leadership roles, leading business operations globally, for companies including Bayer, Pfizer, Bristol-Myers Squibb, and Sanofi. He also led the launch and marketing of products across numerous therapeutic categories, including primary care, specialty care, and oncology. He is currently Chairman of the Board of Replimune (REPL), Member of the Board of Directors FieldTrip Health (FTRPF), Chairman of the Board of Directors of ForeBio, Chairman of the Board of Mnemo. and Executive Chairman of the Board of ZielBioPharma.